Patents by Inventor Heide Ford

Heide Ford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Predicting TGF-beta Therapeutic Responses
    Publication number: 20130243787
    Abstract: The invention provides methods of determining whether a cancer in a subject is responsive to anti-TGF-? therapy. In some embodiments, the invention further provides for the administration of an anti-TGF-? therapy cancer therapy to the subject.
    Type: Application
    Filed: September 6, 2012
    Publication date: September 19, 2013
    Inventors: Heide Ford, Anna Smith
  • Methods for determining prognoses and therapeutic interventions for ovarian carcinomas
    Patent number: 8283119
    Abstract: Methods for determining the prognosis and therapeutic interventions for cancer and for utilizing the expression of the homeoprotein Six1 to determine the prognosis and therapeutic interventions for cancer, in particular for ovarian carcinomas.
    Type: Grant
    Filed: December 11, 2007
    Date of Patent: October 9, 2012
    Assignee: The Regents of the University of Colorado, A Body Corporate
    Inventors: Heide Ford, Kian Behbakht, Andrew Thorburn
  • MIRNA INHIBITION OF SIX1 EXPRESSION
    Publication number: 20120190729
    Abstract: The invention provides a method of treating cancer in a subject comprising administering to said subject an miRNA that inhibits Six1. In some embodiments, the invention further provides for the administration of a second cancer therapy to the subject.
    Type: Application
    Filed: July 27, 2010
    Publication date: July 26, 2012
    Applicant: The Regents of The University of Colorado A Body Corporate
    Inventors: Heide Ford, Anna Smith, David Poticha
  • METHODS FOR DETERMINING PROGNOSES AND THERAPEUTIC INTERVENTIONS FOR OVARIAN CARCINOMAS
    Publication number: 20100099095
    Abstract: Methods for determining the prognosis and therapeutic interventions for cancer and for utilizing the expression of the homeoprotein Six1 to determine the prognosis and therapeutic interventions for cancer, in particular for ovarian carcinomas.
    Type: Application
    Filed: December 11, 2007
    Publication date: April 22, 2010
    Applicant: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: Heide Ford, Kian Behbakht, Andrew Thorburn
  • Methods and compositions for the diagnosis and treatment of cyclin A-1 associated conditions
    Publication number: 20060078903
    Abstract: The present invention relates to compositions and methods for cancer therapeutics. In particular, the present invention provides compositions and methods for inhibiting cancer metastasis by inhibiting cyclin A1.
    Type: Application
    Filed: April 25, 2005
    Publication date: April 13, 2006
    Applicants: The Regents of the University of Colorado, a Body Corporate, The Dana-Farber Cancer Institute
    Inventors: Heide Ford, Ricardo Coletta, Arthur Pardee, Justin Lamb